(Q57374670)

2

0 references

Ryan G. Master

3

0 references

Bruce A. Bunnell

4

0 references

Bradley K. Taylor

5

0 references

Subramanyam N. Murthy

6

0 references

Albert L. Hyman

7

0 references

Philip J. Kadowitz

American Journal of Physiology Heart and Circulatory Physiology

8

0 references

publication date

February 2007

0 references

published in

0 references

volume

292

0 references

issue

2

0 references

page(s)

H1120-H1128

0 references

cites work

Role of COX-1 and -2 in prostanoid generation and modulation of angiotensin II responses

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Cell-based gene transfer to the pulmonary vasculature: Endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Gene transfer of endothelial nitric oxide synthase to the lung of the mouse in vivo. Effect on agonist-induced and flow-mediated vascular responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Primary pulmonary hypertension: survival benefits of therapy with prostacyclin analogs and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Adenoviral gene transfer of eNOS: high-level expression in ex vivo expanded marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Engineering ex vivo-expanded marrow stromal cells to secrete calcitonin gene-related peptide using adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Marrow-derived cells as vehicles for delivery of gene therapy to pulmonary epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Alterations of endothelium and smooth muscle function in monocrotaline-induced pulmonary hypertensive arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Mechanical stress promotes the expression of smooth muscle-like properties in marrow stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Disruption of endothelial-cell caveolin-1alpha/raft scaffolding during development of monocrotaline-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Gene transfer of human prostacyclin synthase ameliorates monocrotaline-induced pulmonary hypertension in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Marrow stromal cells as stem cells for nonhematopoietic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Primary pulmonary hypertension. A national prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Changing potency by spontaneous fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006

Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2006